Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Medicenna Therapeutics Corp.

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Therapeutics Announces Participation in Upcoming Conferences
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Announces Results of Annual Meeting of Shareholders
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Tickers MDNAF TSX:MDNA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.